Effectiveness of a digital lifestyle management intervention (levidex) to improve quality of life in people with multiple sclerosis: results of a randomized controlled trial

Abstract Background Multiple Sclerosis (MS) is a chronic inflammatory neurodegenerative disease with diverse symptomatology, significantly impacting patients’ quality of life (QoL). While pharmacological therapies focus primarily on reducing inflammation and relapse rates, non-pharmacological interv...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Björn Meyer, Linda T. Betz, Gitta A. Jacob, Nicole Krause, Karin Riemann-Lorenz, Stefan M. Gold, Jana Pöttgen, Christoph Heesen
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2024-09-01
Ráidu:	BMC Neurology
Fáttát:	Multiple sclerosis Digital health application Quality of life Randomized controlled trial Levidex MS symptom management
Liŋkkat:	https://doi.org/10.1186/s12883-024-03843-5
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!